Marketing-authorisation holder
B.Braun Medical Inc.
63 medicines in 1 country, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder
63 medicines in 1 country, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 63
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| 0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 200 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canada | Marketed | 1998 |
| 0.45% SODIUM CHLORIDE INJECTION USP4.5 mg / ml · Solution | Sodium chloride | Canada | Marketed | 1993 |
| 0.9% SODIUM CHLORIDE INJECTION USP0.9 % · Solution | Sodium chloride | Canada | Marketed | 1992 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP0.9 % · Solution | Sodium chloride | Canada | Not marketed | 1992 |
| 0.9% SODIUM CHLORIDE IRRIGATION USP0.9 % · Solution | Sodium chloride | Canada | Authorised | |
| 10% DEXTROSE INJECTION USP100 mg / ml · Solution | Dextrose | Canada | Marketed | 1993 |
| 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Sodium chloride | Canada | Not marketed | 1992 |
| 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 200 mg / 100 ml · Solution | Dextrose, Sodium chloride | Canada | Not marketed | 1996 |
| 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Sodium chloride | Canada | Marketed | 1992 |
| 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP50 mg / ml + 9 mg / ml · Solution | Dextrose, Sodium chloride | Canada | Marketed | 1992 |
| 5% DEXTROSE INJECTION USP50 mg / ml · Solution | Dextrose | Canada | Marketed | 1993 |
| 5% SODIUM CHLORIDE INJECTION USP5 g / 100 ml · Solution | Sodium chloride | Canada | Marketed | 1993 |
| 70% DEXTROSE INJECTION USP70 g / 100 ml · Solution | Dextrose | Canada | Authorised | |
| HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ5 g / 100 ml + 4000 unit / 100 ml · Solution | Dextrose, Heparin | Canada | Marketed | 1996 |
| HEPARIN SODIUM 25000UNITS IN 5% DEXTROSE INJ5 g / 100 ml + 10000 unit / 100 ml · Solution | Dextrose, Heparin | Canada | Marketed | 1996 |
| HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION37 mg / 100 ml + 200 unit / 100 ml + 900 mg / 100 ml + 430 mg / 100 ml · Solution | Citric acid, Heparin, Sodium chloride, Dibasic | Canada | Not marketed | 1996 |
| HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML93 mg / 100 ml + 5 g / 100 ml + 5000 unit / 100 ml + 410 mg / 100 ml · Solution | Citric acid, Dextrose, Heparin, Dibasic | Canada | Marketed | 1993 |
| ISOLYTE S (MULTI-ELECTROLYTE INJECTION)30 mg / 100 ml + 37 mg / 100 ml + 370 mg / 100 ml + 530 mg / 100 ml + 500 mg / 100 ml · Solution | Magnesium chloride, Potassium chloride, Sodium acetate, Sodium chloride, Sodium gluconate | Canada | Marketed | 1992 |
| ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION)30 mg / 100 ml + 37 mg / 100 ml + 820 mcg / 100 ml + 370 mg / 100 ml + 530 mg / 100 ml + 500 mg / 100 ml + 12 mg / 100 ml · Solution | Magnesium chloride, Potassium chloride, Monobasic, Sodium acetate, Sodium chloride, Sodium gluconate, Dibasic | Canada | Marketed | 1996 |
| LACTATED RINGER'S INJECTION USP20 mg / 100 ml + 30 mg / 100 ml + 600 mg / 100 ml + 310 mg / 100 ml · Solution | Calcium chloride, Potassium chloride, Sodium chloride, Sodium lactate | Canada | Marketed | 1992 |
| MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP500 mg / container · Powder For Solution | Meropenem | Canada | Marketed | 2025 |
| MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP1 g / container · Powder For Solution | Meropenem | Canada | Marketed | 2025 |
| POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP149 mg / ml · Solution | Potassium chloride | Canada | Marketed | 2020 |
| RINGER'S INJECTION USP33 mg / 100 ml + 30 mg / 100 ml + 860 mg / 100 ml · Solution | Calcium chloride, Potassium chloride, Sodium chloride | Canada | Not marketed | 1996 |
| STERILE WATER FOR INJECTION USP100 % · Liquid | Water | Canada | Marketed | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 63 | 27 | 36 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.